ASCL1 and small cell lung carcinoma: As expected, chemo-naive SCLC cohorts were predominantly enriched for ASCL1+ tumors (George-SCLC, Liu and Jiang cohorts), whereas the highly treated Lissa cohort had higher prevalence of YAP1+ tumors (Fig. 2A).